Mitochondrial complex I inhibition has been implicated in the degeneration of midbrain dopaminergic (DA) neurons in Parkinson's disease. However, the mechanisms and pathways that determine the cellular fate of DA neurons downstream of the mitochondrial dysfunction have not been fully identified. We conducted celltype specific gene array experiments with nigral DA neurons from rats treated with the complex I inhibitor, rotenone, at a dose that does not induce cell death. The genome wide screen identified transcriptional changes in multiple cell death related pathways that are indicative of a simultaneous activation of both degenerative and protective mechanisms. Quantitative PCR analyses of a subset of these genes in different neuronal populations of the basal ganglia revealed that some of the changes are specific for DA neurons, suggesting that these neurons are highly sensitive to rotenone. Our data provide insight into potentially defensive strategies of DA neurons against disease relevant insults.
Introduction
Although many neuronal populations are affected in Parkinson disease (PD), dopaminergic (DA) neurons in the substantia nigra pars compacta (SNC) are among the most severely affected and their death leads to major neurological disability (Hirsch et al., 1988; Fearnley and Lees, 1991) . With the exception of rare hereditary forms of the disease, the causes of PD are not known. Deletions of mitochondrial DNA (Bender et al., 2006) and a decreased activity of complex I of the respiratory chain (Schapira et al., 1989; Schapira et al., 1990; Mann et al., 1992; Swerdlow et al., 1996) have implicated mitochondrial dysfunction in the degenerative process occurring in sporadic PD. This hypothesis is further supported by evidence that two ion channels that are expressed by SNC-DA neurons render these neurons more susceptible to oxidative stress (Liss et al., 2005 , Chan et al., 2007 . Despite increasing knowledge about the mechanisms responsible for the vulnerability of DA neurons to oxidative stress, the downstream molecular responses to the insult are not well understood.
To identify cellular pathways and mechanisms that are activated at an early stage of mitochondrial dysfunction in SNC-DA neurons we performed transcriptional analyses of these neurons in rats treated with low doses of the mitochondrial complex I inhibitor rotenone (Sherer et al., 2003a) . Rotenone has been shown to reproduce key features of PD, including motor deficits and a variable loss of DA neurons and terminals (Betarbet et al., 2000; Alam and Schmidt, 2002; Sherer et al., 2003b , Fleming et al., 2004 . However, the vulnerability of SNC-DA neurons to rotenone, and the selectivity of the insult highly depend on experimental conditions and vary in individual animals (Höglinger et al, 2003; Zhu et al., 2004) .
For the present study, our goal was to produce a low level insult that possibly affected DA neurons without inducing rapid cell loss. Our previous studies have shown that after administration of 2.0 mg/kg/ day s.c. for 3 weeks, a high percentage of surviving animals have normal cell counts of DA neurons in the SNC and normal TH protein expression levels in the striatum despite their clearly detectable motor impairment (Fleming et al., 2004; Zhu et al., 2004) . To further reduce the risk of inducing a structural deficit, we reduced the exposure time to one week. We then selected a subset of animals with both weight loss and behavioral impairment but without a loss of tyrosine hydroxylase-(TH) positive fibers in the striatum, and performed transcriptome analyses of laser-capture microdissected DA neurons (Bonaventure et al., 2002; Kamme et al., 2004 
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